Welcome to Medications.com

Fosamax Plus D News

Generic Fosamax on the Way - FDA news (subscription)

Watson will market the 35- and 70-mg dosage strengths of Fosamax (alendronate sodium). Merck’s other formulation of the drug, Fosamax Plus D (alendronate ...

http://fdanews.com/newsletter/art... | Posted: Tue Feb 12 18:05:05 -0500 2008

Merck & Co: too little too late in osteoporosis market - Pharmaceutical Business Review

The reformulation of Fosamax to include vitamin D, marketed as Fosamax Plus D/Fosavance, was the most successful of these strategies, generating additional ...

http://www.pharmaceutical-busines... | Posted: Thu Feb 07 03:17:00 -0500 2008

3 generic versions of Fosamax launched - Forbes

Two other drugs made by Merck, called Fosamax Plus D, with different doses of vitamin D to increase calcium absorption by the bones, still have patent ...

http://www.forbes.com/markets/fee... | Posted: Wed Feb 06 17:23:28 -0500 2008

3 generic versions of Fosamax launched - BusinessWeek

Two other drugs made by Merck, called Fosamax Plus D, with different doses of vitamin D to increase calcium absorption by the bones, still have patent ...

http://www.businessweek.com/ap/fi... | Posted: Wed Feb 06 14:18:19 -0500 2008

Merck Pays More Than $400 Million to Settle Federal, State ... - PR Newswire (press release)

Merck employed four schemes to grab or maintain market share for drugs including Vioxx(R), Zocor(R), Cozaar(R), Fosamax(R), Maxalt(R), and Singulair(R), ...

Posted: Thu Feb 07 12:46:47 -0500 2008

Lookahead: Retail Check-Up - Wall Street Journal

... generic" version of Fosamax with an unidentified partner. Patent protection for a related product, Fosamax Plus D, is expected to expire in April.

Posted: Fri Feb 01 16:54:48 -0500 2008

Vioxx Charges Hit Merck - TheStreet.com

Bone-density drugs Fosamax and Fosamax Plus D accounted for $796 million in sales in the fourth quarter, an increase of 1% over the year-ago quarter. ...

http://www.thestreet.com/s/vioxx-... | Posted: Wed Jan 30 11:53:55 -0500 2008

Under The Radar News - Wednesday - Seeking Alpha

Merck's (MRK) osteoporosis treatment, Fosamax, faces increasing scrutiny and lawsuits after a growing number of patients say the drug causes a bone-wasting ...

Posted: Wed Jan 30 10:17:46 -0500 2008

Lookahead: Retail Check-Up - Wall Street Journal

... generic" version of Fosamax with an unidentified partner. Patent protection for a related product, Fosamax Plus D, is expected to expire in April.

http://online.wsj.com/article/SB1... | Posted: Fri Feb 01 16:54:48 -0500 2008

Under The Radar News - Wednesday - Seeking Alpha

Sources say Dell (DELL) will to drop the 'corporate axe' on its 150 plus Dell Direct Stores. Separately, Dell laid off an undisclosed number of workers ...

http://seekingalpha.com/article/6... | Posted: Wed Jan 30 10:17:46 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea